On March 20, 2024, The USPTO issued an alert, notifying practitioners that the USPTO had developed training materials for patent examiners regarding searching for prior art in FDA and NIH databases. ...more
3/25/2024
/ Biotechnology ,
Food and Drug Administration (FDA) ,
Healthcare ,
Intellectual Property Protection ,
National Institute of Health (NIH) ,
Over The Counter Drugs (OTC) ,
Patent Examinations ,
Pharmaceutical Industry ,
Prescription Drugs ,
Prior Art ,
Training Requirements ,
USPTO
TRAXCELL TECHNOLOGIES, LLC V. NOKIA SOLUTIONS AND NETWORKS Before Prost, O’Malley, and Stoll.
Appeal from the Eastern District of Texas.
Summary: An applicant’s arguments distinguishing prior art during patent...more
Before Moore, Taranto, and Chen. Appeal from the Patent Trial and Appeal Board.
Summary: The mere fact that a certain thing may result from a given set of circumstances is not sufficient to demonstrate inherency. Instead,...more
Federal Circuit Summaries -
Before Lourie, O’Malley, and Wallach. Appeal from the Patent Trial and Appeal Board.
Summary: The PTAB’s finding that an element in a prior art reference is “similar to” a claim limitation,...more